5-Hydroxytryptamine release into human jejunum by cholera toxin

Gut

Volumn 39, Issue 4, 1996, Pages 528-531

  Bearcroft, C P ^a,c   Perrett, D ^b   Farthing, M J G ^a  

^a Digestive Diseases Research Centre   (United Kingdom)

^b Department of Medicine ^*

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

5 hydroxyindoleacetic acid; 5 hydroxytryptamine; Cholera toxin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHOLERA TOXIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; JEJUNUM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN RELEASE; VOLUNTEER;

EID: 0029964719     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.4.528     Document Type: Article

References (13)

1. Carpenter C. The pathophysiology of secretory diarrhoeas. Med Clin 1982; 66: 597-610.
2. Powell D, Field M. Pharmacological approaches to treatment of secretory diarrhea. In: Field M, Fordtran J, Schultz S, ed. Secretory diarrhea. Bethesda: American Physiological Society 1980: 187-207.
3. Bennett A. Cholera and prostaglandins. Nature 1971; 231: 536.
4. Nilsson O, Cassuto J, Larsson P-A, Jodal M, Lindberg P, Ahlman H, et al. 5-Hydroxytryptamine and choiera secretion: a histochemical and physiological study in cats. Gut 1983; 24: 542-8.
5. 2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology 1989; 96: 368-76.
6. Turvill J, Mourad F, Perrett D, Farthing M. Tissue 5-hydroxytryptamine (5-HT) content in rat small intestine in absorptive and secretory states. Gut 1994; 35 (suppl 5): S54.
7. Cassuto J, Jodal M, Tuttle R, Lundgren O. 5-hydroxytryptamine and cholera secretion. Physiological and pharmacological studies in cats and rats. Scand J Gastroenterol 1982; 17: 695-703.
8. 3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion in the rat. Gastroenterology 1990; 99: 83-9.
9. Mourad F, O'Donnell L, Dias J, Ogutu E, Farthing M. Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera toxin and Eschenchia coli enterotoxins. Gut 1995; 37: 340-5.
10. Hunt J, Thillainayagam A, Carnaby S, Fairclough P, Clark M, Farthing M. A new model of human secretory diarrhoea using cholera toxin. Aliment Pharmacol Ther 1992; 6: 619-27.
11. Hunt J, Elliot E, Farthing M. Efficacy of a standard United Kingdom oral rehydration solution (ORS) and a hypotonic ORS assessed by human intestinal perfusion. Aliment Pharmacol Ther 1989; 3: 565-71.
12. Hicks T, Turnberg L. The influence of secretin on ion transport in the human jejunum. Gut 1973; 14: 485-90.
13. Bearcroft C, Farthing M, Perrett D. Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in plasma and urine by HPLC with fluorimetric detection. Biomed Chromatogr 1995; 9: 23-7.